Current chemotherapy of schistosomiasis in Japan.
D013184:5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D000965:Antimony / Q000627:therapeutic use; D002648:Child; D006224:Cricetinae; D006801:Humans; D006826:Hycanthone / Q000009:adverse effects / Q000627:therapeutic use; D051379:Mice; D009560:Niridazole / Q000009:adverse effects / Q000627:therapeutic use; D051381:Rats; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000627:therapeutic use*; D014372:Tubercidin / Q000627:therapeutic use
D012556:Schistosomicides; D013184:5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole; D006826:Hycanthone; D000965:Antimony; D014372:Tubercidin; D009560:Niridazole